RxDoctor Payments Data

Kelly Radford, DO

Family Medicine · Kings Mountain, NCNPI 1750763876

Payments from drug & device makers

$756in general payments, 2019–2025

Across 59 payments — averaging $12.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$146
  • AstraZeneca$134
  • Takeda Pharmaceuticals U.S.A., Inc.$106
  • GSK$88
  • Lilly USA, LLC$55
  • Genentech USA, Inc.$50
  • plus $178 from 8 others

What the payments were for

  • Food & beverage$73797%
  • Education$193%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$756 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$46,039
Medicare patients
136
Services billed
593

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$112,045
JardianceEmpagliflozin39$48,207
EliquisApixaban26$30,355
MounjaroTirzepatide21$26,687
TrulicityDulaglutide13$12,231
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$8,254
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,259
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,681
Gabapentin96$1,510
Atorvastatin Calcium151$1,443
Omeprazole92$1,293
Albuterol Sulfate HfaAlbuterol Sulfate57$1,244
Losartan Potassium134$1,158
Ventolin HfaAlbuterol Sulfate19$1,088
LantusInsulin Glargine,hum.Rec.Anlog14$1,055

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$146$112,04570 claims
Boehringer IngelheimJardiance$28$48,20739 claims
Lilly USA, LLCMounjaro, Trulicity$55$38,91834 claims
PfizerEliquis$27$30,35526 claims
GSKTrelegy Ellipta$88$7,25911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Kings Mountain

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →